Professor Bela Paizs is an expert in computational and biological mass spectrometry and related informatics with a PhD in theoretical chemistry.
He was Heisenberg fellow (2009-12) of the German Research Council (DFG) and run the Computational Proteomics group at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. He is currently also Professor of Chemistry at Bangor University, Bangor, UK. He is one of the two UK-based Biemann Awardees of the American Society for Mass Spectrometry. This award “recognizes a significant achievement in basic or applied mass spectrometry made by an individual early in his or her career” and was given to him for “seminal contributions to a comprehensive understanding of peptide ion fragmentation.”
Professor Zoltan Takats is the Professor of Analytical Chemistry at the Department Surgery and Cancer, Imperial College London. He provides extensive experience in the development and commercialization of mass spectrometry based analytical systems for clinical diagnostics.
As the founder of Prosolia Inc, Medimass Ltd and Massprom Ltd, he has extensive experience in the development of analytical and medical devices.
He has participated in pioneering research that led to the foundation of the field generally termed as ‘ambient mass spectrometry’ and was the primary inventor of Desorption Electrospray Ionization and Rapid Evaporative Ionization Mass Spectrometry besides 14 other mass spectrometry-related technologies.
Peter Paizs obtained his LLB Laws degree from University College London in 2016, having extensively studied Company, Contract and Property Law.
Thereupon Peter joined RSM UK (part of RSM International, the sixth largest accountancy professional services network in the world). At RSM he spent time in both Corporate Finance (Mergers & Acquisitions) and Business Advisory (Accounting).
Peter is a member of the ICAEW, recently having part-qualified for the ACA.
At Deshape Peter is in charge of the administration of the Company including legal, regulatory and compliance duties. He also ensures that the Company's financial performance is optimised by designing and measuring appropriate KPI's thus making sure that cost and profit targets are met.